DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR
Background: Sofosbuvir (SOF) and daclatasvir (DCV) are usually prescribed in combination for the treatment of hepatitis C worldwide. Objectives: In the present study a novel, simple, rapid, and cost-effective reversed-phase high performance liquid chromatography (HPLC) method was developed, optimis...
Saved in:
Main Authors: | Syed Hassan Murtaza, Ahmed Umer Sohaib Ahmed, Tassawer-e-Meran, Sonam Anees, Najam-ul-Hassan Khan, Kishwar Sultana |
---|---|
Format: | Article |
Language: | English |
Published: |
Superior University Lahore, Pakistan
2024-03-01
|
Series: | International Journal of Pharmacy & Integrated Health Sciences |
Subjects: | |
Online Access: | https://ijpihs.pk/index.php/IJPIHS/article/view/118 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of sofosbuvir plus daclatasvir in hemodialysis patients with genotype 1b or 2a hepatitis C virus infection: a single-arm, prospective real-world study
by: Kaili Wang, et al.
Published: (2025-07-01) -
Evaluation of the effi cacy and safety of the use of asunaprevir in combination with daclatasvir in patients with chronic hepatitis С: a prospective cohort study
by: Elena B. Romanova, et al.
Published: (2017-12-01) -
Eradication of hepatitits C virus in patient with cryoglobulinemic vasculitis and mutations D168E, L31V
by: N. V. Dunaeva, et al.
Published: (2020-03-01) -
Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2
by: Rui Shu, et al.
Published: (2025-07-01) -
Evaluation of possible approaches to the determination by the method rp hplc natural oils in repellent compositions
by: L. A. Nosikova, et al.
Published: (2015-10-01)